Mapping energy metabolism in patients with peripheral arterial disease using MRI.

MRI based phosphocreatine mapping method to assess patients with peripheral arterial disease.

NIH-funded research Hugo W. Moser Res Inst Kennedy Krieger · NIH-10677775

This study is exploring a new way to check how well your muscles are working if you have peripheral arterial disease (PAD) by using a special type of MRI that looks at energy levels in your muscles, which could help doctors understand your condition better and find the right treatments for you.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHugo W. Moser Res Inst Kennedy Krieger NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-10677775 on NIH RePORTER

What this research studies

This research investigates a new method to assess patients with peripheral arterial disease (PAD) by mapping phosphocreatine levels in skeletal muscle using advanced MRI techniques. Current assessments often fail to correlate with the functional limitations experienced by PAD patients, leading to a need for more specific tests. The study aims to utilize chemical exchange saturation transfer (CEST) MRI to noninvasively measure and visualize energy metabolism in muscle tissue, potentially providing insights into the severity of ischemia and mitochondrial function. This approach could help identify patients who may benefit from targeted therapies and improve their quality of life.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with peripheral arterial disease who experience functional limitations and symptoms related to muscle ischemia.

Not a fit: Patients without peripheral arterial disease or those with non-ischemic muscle conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more accurate assessments of muscle function in PAD patients, guiding better treatment strategies.

How similar studies have performed: While the use of CEST MRI is a novel approach, previous studies have shown promise in using advanced imaging techniques to assess metabolic function in various conditions.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Atherosclerotic Cardiovascular Diseaseatherosclerotic diseaseatherosclerotic vascular disease
Last reviewed 2026-06-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.